Create Account
Sign In
LightDark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
News
Brokers

ARDX
Ardelyx Inc
stock NASDAQ

Market Open
10/20/2021 9:30:30 AM EDT
1.06USD+0.952%(+0.01)80,238
1.05Bid   1.11Ask   0.06Spread IEX
Pre-market
10/13/2021 9:12:07 AM EDT
0.9898USD-5.733%(-0.0602)0
After-hours
10/13/2021 4:09:00 PM EDT
1.09USD+0.461%(+0.01)0
OverviewNewsOption ChainHistoricalStats
Oct 14, 2021
11:18AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021   Benzinga
09:59AM EDT  Ladenburg Thalmann Downgrades Ardelyx to Neutral   Benzinga
Oct 13, 2021
01:38PM EDT  Ardelyx Says Met With FDA In Type A Meeting But Was Not Provided Sufficient Clarity On What Constitutes 'clinical relevance of the magnitude of treatment effect'; Awaits Additional Info Regarding Path For Tenapanor NDA   Benzinga
08:37AM EDT  Ardelyx Awaiting Next Steps From FDA To Resubmit NDA For   RTTNews
08:13AM EDT  Ardelyx Continues To Await Clarity From FDA On Path Forward For Approval Of Tenapanor For Hyperphosphatemia   RTTNews
08:01AM EDT  Ardelyx Provides Corporate Update Following Type A Meeting with FDA   PR Newswire
Sep 28, 2021
09:09AM EDT  Ardelyx Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds   PR Newswire
Sep 24, 2021
09:58AM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Ardelyx Inc. (NASDAQ: ARDX) (Ardelyx) on behalf of those who purchased or acquired Ardelyx securities between August 6, 2020 and July 19, 2021, inclusive (the Class Period).   GlobeNewswire Inc
Sep 23, 2021
07:20PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Sep 18, 2021
10:02AM EDT  ARDX INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP   GlobeNewswire Inc
Sep 17, 2021
05:39PM EDT  Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities   PR Newswire
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 15, 2021
09:14PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Sep 10, 2021
08:16PM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Ardelyx Inc. (NASDAQ: ARDX) (Ardelyx) on behalf of those who purchased or acquired Ardelyx securities between August 6, 2020 and July 19, 2021, inclusive (the Class Period).   GlobeNewswire Inc
Sep 6, 2021
09:17PM EDT  Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class   PR Newswire
Sep 3, 2021
08:04AM EDT  Ardelyx Announces Publication Of 52-week Phase 3 PHREEDOM Trial In American Society Of Nephrology Journal, Kidney360   RTTNews
08:01AM EDT  Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial   PR Newswire
08:01AM EDT  Ardelyx Highlights Publication Of 52-Week Phase 3 PHREEDOM Trial   Benzinga
Sep 1, 2021
09:06AM EDT  CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds   GlobeNewswire Inc
Aug 31, 2021
09:06PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Aug 29, 2021
07:11PM EDT  Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against   PR Newswire
Aug 21, 2021
02:12PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
11:16AM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Ardelyx Inc. (NASDAQ: ARDX) (Ardelyx) on behalf of those who purchased or acquired Ardelyx securities between August 6, 2020 and July 19, 2021, inclusive (the Class Period).   GlobeNewswire Inc
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
09:45PM EDT  Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of   PR Newswire
Aug 13, 2021
07:51PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
04:12PM EDT  Ardelyx Files for Common Stock Offering of Up to $150M - Sec Filing   Benzinga
12:33PM EDT  Return on Capital Employed Overview: Ardelyx   Benzinga
08:45AM EDT  Ardelyx: Q2 Earnings Insights   Benzinga
08:04AM EDT  Ardelyx Q2 Net Loss $45.2 Mln Vs. Loss $25.0 Mln Prior Year   RTTNews
08:01AM EDT  Ardelyx Q2 EPS $(0.45) Down From $(0.28) YoY, Sales $1.31M Down From $1.84M YoY   Benzinga
08:01AM EDT  Ardelyx Reports Second Quarter 2021 Financial Results   PR Newswire
Aug 12, 2021
06:10PM EDT  Pomerantz Law Firm Announces the Filing of a Class Action Against Ardelyx, Inc.   PR Newswire
01:30PM EDT  Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Ardelyx, Inc. (Ardelyx or the Company) (NASDAQ: ARDX) in the United States District Court for the Northern District of California on behalf of those who purchased or otherwise acquired Ardelyx publicly traded securities between August 6, 2020 and July 19, 2021, inclusive (the Class Period).   GlobeNewswire Inc
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 11, 2021
05:55PM EDT  Ardelyx Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of   PR Newswire
Aug 10, 2021
02:13PM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Ardelyx Inc. (NASDAQ: ARDX) (Ardelyx) on behalf of those who purchased or acquired Ardelyx securities between August 6, 2020 and July 19, 2021, inclusive (the Class Period).   GlobeNewswire Inc
Jul 30, 2021
09:12PM EDT  ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm   Business Wire
Jul 29, 2021
04:40PM EDT  Ardelyx Says FDA Willing To MEet With Co. To Discuss Options For Obtaining Approval   Benzinga
04:40PM EDT  UPDATE: FDA Noted For Application To Be Approved, Ardelyx Must Conduct Additional Adequate Trial Demonstrating 'clinically relevant treatment effect on serum phosphorus or an effect on the clinical outcome thought to be caused by hyperphosphatemia'   Benzinga
04:38PM EDT  Ardelyx Receives CRL From FDA For NDA For Tenapanor For Control Of Serum Phosphorus In Adult Patients With CKD On Dialysis; FDA Said They 'characterize the magnitude of the treatment effect as "small and of unclear clinical significance."'   Benzinga
04:02PM EDT  Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis   PR Newswire
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
Jul 27, 2021
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 23, 2021
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga
Jul 21, 2021
08:20AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
08:01AM EDT  Clinicaltrials.gov Site Showes Ardelyx Vehicle-Controlled Phase 2 Trial To Assess Subjects With Dry Eye Disease Now Recruiting   Benzinga
07:52AM EDT  The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay   Benzinga
06:11AM EDT  Jefferies Downgrades Ardelyx to Hold, Lowers Price Target to $2   Benzinga
Jul 20, 2021
02:56PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher   Benzinga
12:10PM EDT  Mid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide   Benzinga
10:26AM EDT  Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results   Benzinga
10:14AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021   Benzinga
08:28AM EDT  (ARDX) Alert: Johnson Fistel, Investigates Ardelyx Following FDA Notification.   PR Newswire
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
08:13AM EDT  Shares of biopharmaceutical company Ardelyx, Inc. (ARDX) are down more than 70% in pre-market on Tuesday.   RTTNews
07:45AM EDT  Wedbush Downgrades Ardelyx to Neutral, Announces $3 Price Target   Benzinga
05:56AM EDT  Piper Sandler Downgrades Ardelyx to Neutral, Lowers Price Target to $4   Benzinga
05:12AM EDT  Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease Candidate Pitch   Benzinga
Jul 19, 2021
04:07PM EDT  Ardelyx Shares To Resume Trade At 4:30 p.m. EDT   Benzinga
04:03PM EDT  Ardelyx Receives FDA Letter Regarding NDA For Tenapanor Indicating Deficiencies That Preclude Discussion Of Labeling And Post-marketing Requirements/Commitments At This Time; Co. Says Request For Meeting To Discuss Deficiencies Was Denied   Benzinga
04:01PM EDT  Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for   PR Newswire
Jun 7, 2021
08:01AM EDT  Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021   PR Newswire
May 25, 2021
08:03AM EDT  Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference   PR Newswire
May 6, 2021
08:45AM EDT  Ardelyx Q1 EPS $(0.34) Down From $(0.25) YoY, Sales $6.58M Up From $1.21M YoY   Benzinga
08:02AM EDT  Ardelyx Reports First Quarter 2021 Financial Results and Recent Business   PR Newswire
Apr 30, 2021
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
06:34AM EDT  Ardelyx Stock Plummets As Review Period For Tenapanor US Application Pushed By 3 Months   Benzinga
Apr 29, 2021
04:55PM EDT  Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis   Benzinga
04:16PM EDT  Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the   PR Newswire
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 16, 2021
04:01PM EDT  Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 15, 2021
12:19PM EDT  Mid-Day Market Update: Dow Surges 250 Points; KLX Energy Services Shares Slide   Benzinga
Apr 14, 2021
08:10AM EDT  Ardelyx Partner, Kyowa Kirin, Announces Initiation Of Phase 3 Studies Of Tenapanor For Hyperphosphatemia In Japan   RTTNews
08:05AM EDT  Ardelyx Reports Its Collab Partner, Kyowa Kirin, Initiated Phase 3 Studies Of Tenapanor For Hyperphosphatemia In Japan   Benzinga
08:01AM EDT  Ardelyx Collaboration Partner, Kyowa Kirin, Announces Initiation of Phase 3   PR Newswire
Apr 12, 2021
08:22AM EDT  Ardelyx To Present Data From NORMALIZE At The ISN World Congress Of Nephrology 2021   RTTNews
08:11AM EDT  Ardelyx To Present Data From NORMALIZE Phase 4 Trial At ISN World Congress of Nephrology 2021 Apr. 16-19   Benzinga
08:02AM EDT  Ardelyx Announces Upcoming Data Presentation at ISN World Congress of   PR Newswire
Apr 7, 2021
07:58AM EDT  The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award   Benzinga
Apr 6, 2021
06:59AM EDT  Ardelyx Granted US Patent Titled 'Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists'   Benzinga
Mar 30, 2021
04:02PM EDT  Ardelyx Highlights Poster Presentations, Exhibitor Showcase At National Kidney Foundation Meetings Apr. 6-10, 2021   Benzinga
04:01PM EDT  Ardelyx Announces Poster Presentations, Educational Symposium, and Exhibitor   PR Newswire
Mar 23, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021   Benzinga
06:27AM EDT  Wedbush Initiates Coverage On Ardelyx with Outperform Rating, Announces Price Target of $14   Benzinga
Mar 15, 2021
08:02AM EDT  Ardelyx Appoints Muna Bhanji, R.Ph, to its Board of Directors   PR Newswire
Mar 9, 2021
05:23AM EST  Ardelyx Awarded U.S. Patent 10,940,146 'NHE3-binding compounds and methods for inhibiting phosphate transport'   Benzinga
Mar 8, 2021
10:08AM EST  Ardelyx shares were trading higher after the company reported better-than-expected Q3 EPS and sales results.   Benzinga
08:46AM EST  Ardelyx FY Loss Narrows To $94.3 Mln From $94.9 Mln Prior Year   RTTNews
08:46AM EST  Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent   PR Newswire
08:17AM EST  Ardelyx Q3 EPS $(0.20) Beats $(0.28) Estimate, Sales $2.71M Beat $1.09M Estimate   Benzinga
Feb 17, 2021
08:01AM EST  Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference   PR Newswire
Jan 6, 2021
10:14AM EST  Benzinga's Top Upgrades, Downgrades For January 6, 2021   Benzinga
06:12AM EST  Cantor Fitzgerald Initiates Coverage On Ardelyx with Overweight Rating, Announces Price Target of $14   Benzinga
Dec 12, 2020
01:46PM EST  Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More   Benzinga
Dec 11, 2020
05:35AM EST  Ardelyx Director David Mott Reported Purchase of 170,000 Shares @ Avg Price of $5.89/Share in Form 4 Filing on Thursday   Benzinga
05:10AM EST  SVB Leerink Maintains Outperform on Ardelyx, Raises Price Target to $14   Benzinga
Nov 23, 2020
08:01AM EST  Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare   PR Newswire
Nov 10, 2020
08:02AM EST  Ardelyx to Present at the Jefferies Virtual London Healthcare Conference   PR Newswire
Nov 6, 2020
08:01AM EST  Ardelyx to Webcast Virtual Analyst Day   PR Newswire
Nov 5, 2020
08:08AM EST  Ardelyx Q3 EPS $(0.20) Up From $(0.37) YoY, Sales $2.71M Down From $3.01M YoY   Benzinga
08:02AM EST  Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights   PR Newswire
Oct 22, 2020
10:01AM EDT  Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020   PR Newswire
10:01AM EDT  Ardelyx, Kyowa Kirin Highlight New Clinical Data Presented Within 5 Posters For Kidney Week 2020   Benzinga
08:02AM EDT  Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020   PR Newswire
Oct 12, 2020
08:11AM EDT  Ardelyx Presents Data Supporting Efficacy And Safety Of Tenapanor At ASN's Kidney Week 2020   RTTNews
08:08AM EDT  Ardelyx Highlights Presentation Of Tenapanor Data At ASN's Kidney Week 2020 Oct. 22-25   Benzinga
08:01AM EDT  First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020   PR Newswire
Sep 15, 2020
10:00AM EDT  Shares of Ardelyx, Inc. (ARDX) slipped nearly 6% on Tuesday morning despite no negative stock-related news.   RTTNews
09:23AM EDT  Ardelyx shares are trading higher after the company announced an FDA acceptance for the filing of its new drug application of Tenapor for the control serum Phosphorus in adult patients with CKD on Dialysis.   Benzinga
08:28AM EDT  Ardelyx: FDA Accepts NDA Of Tenapanor For Control Of Serum Phosphorus In Adult Patients With CKD On Dialysis   RTTNews
08:05AM EDT  Ardelyx Announces FDA Acceptance For Filing Of Its New Drug Application Of Tenapor For The Control Serum Phosphorus In Adult Patients With CKD On Dialysis   Benzinga
08:02AM EDT  Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis   PR Newswire
Sep 8, 2020
08:01AM EDT  Ardelyx to Participate in Three Upcoming Investor Conferences in September   PR Newswire
Aug 6, 2020
09:54AM EDT  Ardelyx Earlier Reported Q2 EPS $(0.28) Up From $(0.41) YoY   Benzinga
08:07AM EDT  Ardelyx, Inc. Q2 Net Loss $25 Mln Vs. Net Loss $25.5 Mln Last Year   RTTNews
08:01AM EDT  Ardelyx Reports Second Quarter 2020 Financial Results and Recent Business   PR Newswire
Aug 3, 2020
08:01AM EDT  Ardelyx Selected as a Finalist in the Fierce Innovation Awards for the   PR Newswire




About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
© 2020 - 2021 ChartExchange LLC